Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.47 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.47 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KCNJ11 | Q14654 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8772859 | 0.80 | ALDH1A1 (0.58) | SMN1; SMN2ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL11072219 | 0.78 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL11072217 | 0.78 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL16459527 | 0.77 | SMN1; SMN2 (0.57) | SMN1; SMN2ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL15545332 | 0.77 | SMN1; SMN2 (0.57) | SMN1; SMN2ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL9134643 | 0.77 | ALDH1A1 (0.41) | SMN1; SMN2ALDH1A1DGAT1MAPTCYP1A2 | |
| SCHEMBL11168013 | 0.75 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL10452572 | 0.75 | SMN1; SMN2 (0.72) | SMN1; SMN2ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL5530561 | 0.75 | ADRA2A (0.53) | ADRA2AADRA2BADRA2CALDH1A1KMT2A | |
| SCHEMBL10341394 | 0.74 | SMN1; SMN2 (0.57) | SMN1; SMN2ALDH1A1KMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7763640-B2 | Substituted oxyguanidines | BAYER CORPSCIENCE AG (DE) | 2010-07-27 | — | — | US | disclosed |
| US-20080312297-A1 | Substituted Oxyguanidines | BAYER CROPSCIENCE AG (DE) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312297-A1 | Substituted Oxyguanidines | OGA, CAT, OGG1 | SMN1; SMN2 678/4885ADRA2A 153/4885ADRA2B 263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.